Klebsiella Infections clinical trials
The registry lists 11 studies for Klebsiella Infections across 8 countries. 2 are recruiting or about to start. 3 of them are mainly about Klebsiella Infections (how this is decided). Per ClinicalTrials.gov, last updated 2026-08-04.
Get an email when these change. Save the Klebsiella Infections studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University of Pittsburgh (2) · Wyeth is now a wholly owned subsidiary of Pfizer (2) · Rambam Health Care Campus (1) · University Hospital, Basel, Switzerland (1) · Fondation Hôpital Saint-Joseph (1) · Khon Kaen University (1) · Universidade do Porto (1) · University of Puerto Rico (1)
What is being tested here
Drugs under test in Klebsiella Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Colistin | 0 | 0 | 1 |
| Sitafloxacin | 0 | 1 | 1 |
| Polymyxin B | 0 | 1 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Jan 2027Epidemiology and Overtime Genomic Evolution of Klebsiella Pneumoniae and Enterobacter Cloacae Complex (ECC) in Stools of ICU's Patients · University Hospital, Caen
Who these studies take
Of the 2 Klebsiella Infections studies recruiting now, 2 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (50%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 2 (100%) | 2 (100%) |
| 30 | 2 (100%) | 2 (100%) |
| 40 | 2 (100%) | 2 (100%) |
| 50 | 2 (100%) | 2 (100%) |
| 65 | 2 (100%) | 2 (100%) |
| 75 | 2 (100%) | 2 (100%) |
| 85 | 2 (100%) | 2 (100%) |
Across all 11 studies, recruiting or not: 9% stop at 75 or younger and 0% at 65; 18% take children; 0% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 11 of 11. search them.
- Epidemiology and Overtime Genomic Evolution of Klebsiella Pneumoniae and Enterobacter Cloacae Complex (ECC) in Stools of ICU's PatientsRecruitingNCT077443211 country
- NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant BacteriaRecruitingNCT050177661 country
- Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation PatientsStatus unknownNCT02729116Phase 2/31 country
- Prognosis of Klebsiella ESBL Sepsis: Role of 2-HYDRoxy-myristate in Endotoxin StructureStatus unknownNCT051930451 country
- Effect of a Low Starch Diet in Patients With Ankylosing SpondylitisStatus unknownNCT04386538Not applicable1 country
- Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant PathogensStatus unknownNCT03159078Phase 31 country
- Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella SpeciesCompletedNCT005186611 country
- A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).CompletedNCT01266499Not applicable1 country
- Community - Associated Extended-spectrum Beta-lactamases (ESBL)CompletedNCT003632201 country
- Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive CareCompletedNCT001679861 country
- Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology UnitsCompletedNCT001679991 country